The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder UK Mid & Small Cap Fund Regulatory News (SCP)

Share Price Information for Schroder UK Mid & Small Cap Fund (SCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 582.00
Bid: 584.00
Ask: 586.00
Change: 4.00 (0.69%)
Spread: 2.00 (0.342%)
Open: 582.00
High: 584.00
Low: 582.00
Prev. Close: 578.00
SCP Live PriceLast checked at -
Schroder UK Mid Cap is an Investment Trust

To invest in mid cap equities with the aim of providing a total return in excess of the FTSE 250 (ex-Investment Companies) Index.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

29 Jun 2022 07:00

RNS Number : 5511Q
Schroder UK Mid Cap Fund PLC
29 June 2022
 

Half Year Report and Accounts for the six months ended 31 March 2022

 

Schroder UK Mid Cap Fund plc (the "Company") hereby submits its Half Year Report for the period ended 31 March 2022 as required by the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 4.2.

 

The Half Year Report is also being published in hard copy format and an electronic copy of that document will shortly be available to download from the Company's website www.schroders.co.uk/ukmidcap . Please click on the following link to view the document:

 

http://www.rns-pdf.londonstockexchange.com/rns/5511Q_1-2022-6-28.pdf

 

The Company has also submitted a pdf of the hard copy format of its Half Year Report to the National Storage Mechanism. It will shortly be available for inspection at

https://data.fca.org.uk/#/nsm/nationalstoragemechanism 

 

Enquiries:

Georgina Gearing-Bell

Schroder Investment Management Limited

Tel: 020 7658 6000

 

Chairman's Statement

 

Investment and share price performance

 

During the six-month period to 31 March 2022, the Company's net asset value total return ("NAV") was -11.4% compared to the -9.0% from the Company's Benchmark (FTSE 250 ex Investment Trusts Index). The Company's share price total return was -18.2% over the period as the discount at which the shares trade to net asset value (NAV) widened. Interestingly, trading updates for the companies within the portfolio were generally quite robust and therefore the fall in the Trust's share price in large part reflected a deterioration in general sentiment about the domestic UK economy. Despite these challenging times, it remains the case that shareholders in the Trust have nearly trebled their money over 10 years and the board continues to be optimistic about long-term growth from exposure to this dynamic area of investment.

 

More detailed comment on the performance of your Company may be found in the Manager's review.

 

Discount management

 

Post-period end, the discount to NAV that the shares were trading at presented an attractive opportunity for the Trust to buy-back some shares in the marketplace. Such purchases were accretive to overall shareholder NAV and signalled our belief that the shares were trading at an attractive relative level. A total of 485,000 shares were repurchased by the Company post-period end and placed in treasury.

 

The Board will continue to monitor the level of the discount and will consider further share purchases when the Board believes these are in shareholders' best interests.

 

Revenue and dividends

 

The Board is pleased to announce an interim dividend of 5.0 pence per share. This represents a 32% increase on the interim dividend for last year and is comfortably covered by earnings per share for the period and reflects our confidence in the quality and resilience of the underlying equity portfolio.

 

Gearing

 

Net gearing as at 31 March 2022 was 8.8% vs. 7.7% at the 30 September 2021 year end, as the Manager saw further opportunities in the market to deploy the Company's £25 million revolving credit facility. During the period, the Board approved an additional £10 million three-year revolving loan facility with Scotiabank in addition to the existing £25 million three-year term loan. This should provide the Manager with greater flexibility to exploit attractive investment opportunities as they arise.

 

Outlook

 

In my last Chairman's statement in the Company's 2021 Annual Report, I flagged the emerging threat of inflation as the UK economy recovered rapidly from the damaging effects of the Covid-19 pandemic and likelihood of an increased pace of interest rate rises in response to growing inflationary pressures. During the period under review both inflation and interest rates have continued to rise, exceeding the predictions of most market forecasters. Emerging geopolitical issues have compounded these issues for economies and financial markets, leading to falls across equity markets, with the UK not immune.

 

The Russian invasion of Ukraine in February has led to major disruption to the supply of key commodities including oil, gas and soft commodities such as wheat. This has contributed to a further squeeze on household budgets and a large jump in input costs for companies across sectors. The rising trajectory of interest rates also puts additional pressure on businesses that have become accustomed to borrowing at extremely low cost. The potential of a prolonged conflict in Ukraine is not only tragic on a human level but may lead to ongoing economic and market disruption.

 

Given this backdrop, all equity markets have been under pressure but the UK has held up better than many given both its compositional mix but also due to its low starting valuation compared to most other markets. Many UK companies, outside of the energy and commodity sectors, have de-rated substantially given the challenging economic backdrop, despite reporting robust earnings thus far in 2022 and trading at already low valuations in a global context. International buyers continue to capitalise on the attractive valuation levels of UK companies through increased merger and acquisition activity, especially in the small and mid-cap space. Real value exists around current levels for trade buyers prepared to take a longer-term perspective and look through the current uncertainties.

 

The importance of stock-picking in an environment as uncertain as this cannot be overstated. Our Investment Manager remains cautiously optimistic on the outlook for the remainder of the year given historically cheap valuation levels and remains focused on identifying high-quality and resilient mid-cap companies with strong balance sheets that should be able to withstand the current headwinds. As always, our Manager's focus remains on identifying companies with the potential to be the market leaders of tomorrow whether that be by disrupting the status quo through a unique offering or by their ability to adapt quickly to industry disruption at the expense of their competitors. The companies in your portfolio are operating in niche and growing markets, have healthy balance sheets and are trading at attractive valuations. The attractiveness of current valuation levels is clear from increasing M&A activity, increasing levels of buybacks at many companies and executives continuing to increase personal stakes in their firms. Given the environment, the Manager's approach will be cautiously opportunistic.

 

Robert Talbut

Chairman

 

28 June 2022

 

Manager's Review

 

Market background

 

New Covid-19 variants caused disruption at the beginning of the period before geo-political considerations became central following Russia's invasion of Ukraine. Large cap UK equities performed resiliently as investors priced in the additional inflationary shock of the invasion. In sharp contrast, UK small and mid caps (SMIDs) performed poorly. Consumer focused sectors and a number of overseas and domestically focused industrial areas of the market weighed on these indices. Their greater exposure to secular growth companies also impacted the sector as investors concentrated on the commodity heavy FTSE 100 against a backdrop of soaring resource prices.

 

Portfolio performance

 

The NAV returned a negative 11.4% during the period. The share price returned a significantly greater negative 18.2%, the discount having widened from 7.8% to 15.0% over the period. Both underperformed the benchmark which returned a negative 9.0%.

 

Almost half of the shortfall came from a lack of exposure to utilities names, in particular Centrica and Drax, which benefited during the period from steep rises in energy prices. Our exposure to this theme is instead via multi-utility company Telecom Plus, itself a significant positive contributor during the period. This holding benefited not only from rising energy prices, but also a better competitive positioning which should feed into significant growth in customer numbers.

 

Amongst stocks held, the largest detractor over the six month period was online gaming company 888 Holdings. The market responded poorly to the company's planned financing of its acquisition of William Hill's non-US assets, which, post period end, was renegotiated under more favourable terms and at a lower price. The main drag on performance has been the ongoing gaming sector review in the UK which now looks as though it is coming to a head and should result in more certainty for the industry.

 

Another main detractor was animal genetics company, Genus, primarily due to weakness in the Chinese pig market. However, the company is strongly positioned to benefit from a recovery in China, and is making good progress in stepping through the regulation around its programme to breed and commercialise PRRSv resistant pigs. PRRSv is the most costly infectious disease affecting pigs worldwide. We therefore remain patient holders.

 

IP Group, which invests in the commercialisation of IP with technology, cleantech and life sciences applications, underperformed over the period as falling technology company valuations affected sentiment towards the company's shares. Post the period end, one of its portfolio companies, First Light Fusion, achieved nuclear fusion, underscoring the excitement which exists within the company's holdings.

 

Speciality chemicals business Synthomer was another detractor. The shares underperformed in anticipation of well-flagged tougher comparatives (its medical rubber gloves business benefited from Covid) and because of a change of CEO as the company is making an acquisition. With the new CEO coming from a larger multinational chemicals company, the acquisition taking the company into a still higher margin specialty chemicals niche, and the shares' valuation undemanding in our view, we have retained our holding.

 

Finally, sentiment towards instrumentation and controls business, Spectris, was negatively impacted following an unfortunately timed bid for technology products and services supplier Oxford Instruments. Post the period end, the disposal of the Omega division was positive news, and accompanied the announcement of a £150m share buyback.

 

On the positive side, self storage specialist Safestore, continued to outperform strongly on the back of a strong Q4 trading update and full year earnings upgrades. Safestore remains one of the key overweight positions in the portfolio. Another high conviction portfolio position and one of the top contributors over the period, as well as during the last financial year, was alternative investment manager, Man Group, which performed well as a result of strong financial performance. Robust net inflows (logically) followed strong performance from many of their products. This is another portfolio company which is buying back shares, a theme which has become very common among our holdings and underscores many management teams' confidence in the valuation and balance sheet strength of these companies.

 

Shares in gaming software group, Playtech, also performed very well as the company became the subject of a three-way bidding war. We have since disposed of our position. Staying on the topic of bid targets, wealth manager, Brewin Dolphin, was a key contributor to relative performance following a recommended cash offer from Royal Bank of Canada at a 62% premium.

 

Portfolio activity

 

Over the period, we diversified our real estate exposure by building positions in both Savills and Sirius Real Estate. We initiated our position in the former to gain exposure to the theme of a rapidly changing property landscape as opposed to the owners of the underlying properties. We bought a position in mixed use business park landlord and operator Sirius Real Estate as it raised capital to do an attractive UK deal which complements its German business. The German operations are poised to benefit, in the medium term, from a trend towards near shoring.

 

We also bought a new holding in critical power control solutions provider XP Power. The company supplies the technology, semiconductor fab, healthcare and industrial electronics industries, and is therefore exposed to the structural growth drivers within these industries. Whilst the shares have been under some pressure following the unexpected loss of a legal dispute in March 2022, the position's size during the period has meant that it has had little negative impact. We can, additionally, expect the shares to recover as China emerges from pandemic-related disruption.

 

We initiated a position in London-based leading shipping services provider, Clarkson, whose innovative digital platform, Sea/net, which brings together all aspects of shipping data and services, is showing early signs of success.

 

Another new entrant into the portfolio is mining equipment provider, Weir, as mentioned above.

 

Turning to sales over the period, we disposed of positions in both Dechra Pharmaceuticals and Electrocomponents (now renamed RS Group) following their promotions to the FTSE 100, in line with our stated policy. We exited Playtech as mentioned above.

 

We also sold a residual stake in commercial real estate business CLS Holdings.

 

Outlook

 

Our last outlook statement, published in the 2021 Annual Report in December, commented on "eye catching levels of inflation". The first quarter of 2022 has brought the shock of the invasion of Ukraine by Russia together with existing pandemic-related supply chain issues. This has culminated in inflation rates not seen for a generation and has had an impact on virtually all the companies in the UK market, with the energy and commodity heavy FTSE 100 outperforming relative to most developed world indices.

 

Despite a fairly robust earnings season, then, when many of our holdings have proven that they do, indeed, have pricing power, it has been a tough period for the share prices of UK mid cap companies as a whole. Many companies' shares have de-rated, presumably in anticipation of something even more nasty around the corner.

 

We see US private equity players in particular attempting to profit from this nervousness; it's been a very busy period for merger and acquisition activity. Plenty of UK SMIDs have been acquired or approached in the period (Brewin Dolphin, Playtech and Ted Baker, to name a trio to which we are or have been exposed; another trio, which we do not own, but which strengthens the point, is Homeserve, Countryside Partnerships and The Hut Group). We can expect more of this.

 

Management teams have not failed to notice the value presented by their own shares, and this is reflected in the plethora of share buybacks which have been announced since the beginning of the year. To name a few in the portfolio, in addition to Man Group, mentioned above: Grafton, Pets at Home and Spectris.

 

So, what might the market be anticipating? Although many of our companies have successfully increased prices, a very tight labour market means they are reluctant to reduce staffing levels, and this means that profitability is likely to be tested. The bounce in consumer spending which we had seen has been replaced by a degree of caution as wage increases lag price increases. While this is offset to a degree by excess household savings, and government intervention with regard to energy bills, there is no doubt we have seen a dip in consumer confidence more recently. It remains to be seen how this pans out over the rest of the year. Interestingly, UK corporates appear to be a lot more confident with the Lloyds business barometer showing a marked improvement in May.

 

Being stock pickers, we share some of their cautious optimism, noting the strength of many of our holdings' balance sheets. As ever, we are sticking to our sell discipline, avoiding companies where we think the business model is in danger of being disrupted while seeking out companies which we think are capable of reinventing themselves, or which might be the next mid cap disruptor.

 

Schroder Investment Management Limited

 

28 June 2022

 

Half Year Report

 

Principal risks and uncertainties

 

The Directors consider that the principal risks and uncertainties faced by the Company for the remaining six months of the financial year, which could have a material impact on performance, remain consistent with those on pages 17 to 18 in the Annual Report and Accounts for the year ended 30 September 2021.

 

Going concern

 

Having assessed the Company's principal risks and uncertainties, the impact of the war between Russia and Ukraine and of COVID-19 pandemic, its current financial position, its cash flows, its liquidity position and FRC guidance, the Directors consider it appropriate to adopt the going concern basis in preparing the accounts.

 

Related party transactions

 

There have been no transactions with related parties that have materially affected the financial position or the performance of the Company during the six months ended 31 March 2022.

 

Directors' responsibility statement

 

The Directors confirm that, to the best of their knowledge, this set of condensed financial statements has been prepared in accordance with United Kingdom Generally Accepted Accounting Practice, in particular with Financial Reporting Standard 104 "Interim Financial Reporting" and with the Statement of Recommended Practice, "Financial Statements of Investment Companies and Venture Capital Trusts" issued in April 2021 and that this Interim Management Report includes a fair review of the information required by 4.2.7R and 4.2.8R of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Income Statement

 

For the six months ended 31 March 2022 (unaudited)

 

(Unaudited)

For the six months

ended 31 March 2022

(Unaudited)

For the six months

ended 31 March 2021

(Audited)

For the year

ended 30 September 2021

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

(Losses)/gains on investments

held at fair value through

profit or loss

-

(33,736)

(33,736)

-

46,049

46,049

-

78,136

78,136

Income from investments

3,733

88

3,821

2,376

736

3,112

6,453

736

7,189

Gross return/(loss)

3,733

(33,648)

(29,915)

2,376

46,785

49,161

6,453

78,872

85,325

Investment management fee

 (271)

(633)

(904)

(242)

(564)

(806)

(521)

(1,215)

(1,736)

Administrative expenses

(255)

-

(255)

(259)

-

(259)

(494)

-

(494)

Net return/(loss) before

finance costs and taxation

3,207

(34,281)

(31,074)

1,875

46,221

48,096

5,438

77,657

83,095

Finance costs

(58)

(135)

(193)

(57)

(133)

(190)

(116)

(270)

(386)

Net return/(loss) before taxation

3,149

(34,416)

(31,267)

1,818

46,088

47,906

5,322

77,387

82,709

Taxation (note 3)

-

-

-

-

-

-

-

-

-

Net return/(loss) after taxation

3,149

(34,416)

(31,267)

1,818

46,088

47,906

5,322

77,387

82,709

Return/(loss) per share (note 4)

8.98p

(98.15)p

(89.17)p

5.18p

131.43p

136.61p

15.18p

220.69p

235.87p

 

The "Total" column of this statement is the profit and loss account of the Company. The "Revenue" and "Capital" columns represent supplementary information prepared under guidance issued by The Association of Investment Companies. The Company has no other items of other comprehensive income, and therefore the net return after taxation is also the total comprehensive income for the period.

 

All revenue and capital items in the above statement derive from continuing operations. No operations were acquired or discontinued in the period.

 

Statement of Changes in Equity

 

For the six months ended 31 March 2022 (unaudited)

 

Called-up

Capital

Share

share

Share

redemption

Merger

purchase

Capital

Revenue

capital

premium

reserve

reserve

reserve

reserves

reserve

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

At 30 September 2021

9,036

13,971

220

2,184

9,908

235,367

6,883

277,569

Net (loss)/return after taxation

-

-

-

-

-

(34,416)

3,149

(31,267)

Dividend paid in the period (note 5)

-

-

-

-

-

-

(3,857)

(3,857)

At 31 March 2022

9,036

13,971

220

2,184

9,908

200,951

6,175

242,445

 

For the six months ended 31 March 2021 (unaudited)

 

Called-up

Capital

Share

share

Share

redemption

Merger

purchase

Capital

Revenue

capital

premium

reserve

reserve

reserve

reserves

reserve

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

At 30 September 2020

9,036

13,971

220

2,184

9,908

157,980

6,225

199,524

Net return after taxation

-

-

-

-

-

46,088

1,818

47,906

Dividend paid in the period (note 5)

-

-

-

-

-

-

(3,331)

(3,331)

At 31 March 2021

9,036

13,971

220

2,184

9,908

204,068

4,712

244,099

 

For the year ended 30 September 2021 (audited)

 

Called-up

Capital

Share

share

Share

redemption

Merger

purchase

Capital

Revenue

capital

premium

reserve

reserve

reserve

reserves

reserve

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

At 30 September 2020

9,036

13,971

220

2,184

9,908

157,980

6,225

199,524

Net return after taxation

-

-

-

-

-

77,387

5,322

82,709

Dividends paid in the year (note 5)

-

-

-

-

-

-

(4,664)

(4,664)

At 30 September 2021

9,036

13,971

220

2,184

9,908

235,367

6,883

277,569

 

Statement of Financial Position at 31 March 2022

 

(Unaudited)

(Unaudited)

(Audited)

31 March

31 March

30 September

2022

2021

2021

£'000

£'000

£'000

Fixed assets

Investments held at fair value through profit or loss

261,960

254,666

300,061

Current assets

Debtors

2,434

1,556

1,389

Cash at bank and in hand

3,603

13,400

3,564

6,037

14,956

4,953

Current liabilities

Creditors: amounts falling due within one year (note 6)

(25,552)

(523)

(2,445)

Net current (liabilities)/assets

(19,515)

14,433

2,508

Total assets less current liabilities

242,445

269,099

302,569

Creditors: amounts falling due after more than one year

-

(25,000)

(25,000)

Net assets

242,445

244,099

277,569

Capital and reserves

Called-up share capital (note 7)

9,036

9,036

9,036

Share premium

13,971

13,971

13,971

Capital redemption reserve

220

220

220

Merger reserve

2,184

2,184

2,184

Share purchase reserve

9,908

9,908

9,908

Capital reserves

200,951

204,068

235,367

Revenue reserve

6,175

4,712

6,883

Total equity shareholders' funds

242,445

244,099

277,569

Net asset value per share (note 8)

691.39p

696.11p

791.56p

 

Notes to the Accounts

 

1. Financial Statements

 

The information contained within the accounts in this half year report has not been audited or reviewed by the Company's independent auditor.

 

The figures and financial information for the year ended 30 September 2021 are extracted from the latest published accounts of the Company and do not constitute statutory accounts for that year. Those accounts have been delivered to the Registrar of Companies and included the report of the auditor which was unqualified and did not contain a statement under either section 498(2) or 498(3) of the Companies Act 2006.

 

2. Accounting policies

 

Basis of accounting

 

The accounts have been prepared in accordance with United Kingdom Generally Accepted Accounting Practice, in particular with Financial Reporting Standard 104 "Interim Financial Reporting" and with the Statement of Recommended Practice "Financial Statements of Investment Trust Companies and Venture Capital Trusts" issued by the Association of Investment Companies in April 2021.

 

All of the Company's operations are of a continuing nature.

 

The accounting policies applied to these accounts are consistent with those applied in the accounts for the year ended 30 September 2021.

 

3. Taxation

 

The Company's effective corporation tax rate is nil, as deductible expenses exceed taxable income.

 

4. Return/(loss) per share

 

(Unaudited)

(Unaudited)

(Audited)

For the

For the 

For the

six months

six months

year ended

ended

ended

30 September

31 March 2022

31 March 2021

2021

£'000

£'000

£'000

Revenue return

3,149

1,818

5,322

Capital (loss)/return

(34,416)

46,088

77,387

Total (loss)/return

(31,267)

47,906

82,709

Weighted average number of shares in issue during the period

35,066,190

35,066,190

35,066,190

Revenue return per share

8.98p

5.18p

15.18p

Capital (loss)/return per share

(98.15)p

131.43p

220.69p

Total (loss)/return per share

(89.17)p

136.61p

235.87p

 

5. Dividends

 

(Unaudited)

(Unaudited)

(Audited)

For the

For the

For the

six months

six months

year ended

ended

ended

30 September

31 March 2022

31 March 2021

2021

£'000

£'000

£'000

2021 final dividend paid of 11.0p (2020: 9.5p)

3,857

3,331

3,331

Interim dividend of 3.8p

-

-

1,333

3,857

3,331

4,664

 

An interim dividend of 5.0p (2020: 3.8p) per share, amounting to £1,753,000 (2020: £1,333,000), has been declared payable in respect of the six months ended 31 March 2022.

 

6. Creditors: amounts falling due within one year

 

(Audited)

(Unaudited)

(Unaudited)

30 September

31 March 2022

31 March 2021

2021

£'000

£'000

£'000

Bank Loan

25,000

-

-

Securities purchased awaiting settlement

-

-

1,783

Other creditors and accruals

552

523

662

25,552

523

2,445

 

The bank loan is a £25 million three-year term loan from Scotiabank Europe plc, expiring in February 2023 and carrying a fixed interest rate of 1.546% per annum.

 

7. Called-up share capital

 

(Unaudited)

(Unaudited)

(Audited)

Six months

Six months

Year ended

ended

ended

30 September

31 March 2022

31 March 2021

2021

£'000

£'000

£'000

Ordinary shares of 25p each, allotted, called-up and fully paid

Opening and closing balance of 36,143,690 shares1

9,036

9,036

9,036

1 Including 1,077,500 (31 March 2021 and September 2021: same) shares held in treasury.

 

8. Net asset value per share

 

Net asset value per share is calculated by dividing shareholders' funds by the 35,066,190 (31 March 2021 and 30 September 2021: same) shares in issue, excluding shares held in treasury.

 

9. Financial instruments measured at fair value

 

The Company's financial instruments that are held at fair value comprise its investment portfolio. At 31 March 2022, all investments in the Company's portfolio were categorised as Level 1 in accordance with the criteria set out in paragraph 34.22 (amended) of FRS 102. That is, they are all valued using unadjusted quoted prices in active markets for identical assets (31 March 2021 and 30 September 2021: same).

 

10. Events after the interim period that have not been reflected in the financial statements for the interim period

 

The Directors have evaluated the period since the interim date and have not noted any events which have not been reflected in the financial statements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR UWORRUSUNUUR
Date   Source Headline
7th May 202410:42 amRNSNet Asset Value(s)
3rd May 202411:01 amRNSNet Asset Value(s)
2nd May 202410:50 amRNSNet Asset Value(s)
1st May 20243:15 pmRNSPortfolio Update
1st May 202410:44 amRNSNet Asset Value(s)
30th Apr 202410:25 amRNSNet Asset Value(s)
29th Apr 202410:27 amRNSNet Asset Value(s)
26th Apr 202410:50 amRNSNet Asset Value(s)
25th Apr 202410:48 amRNSNet Asset Value(s)
24th Apr 202410:31 amRNSNet Asset Value(s)
23rd Apr 202411:13 amRNSNet Asset Value(s)
22nd Apr 202410:38 amRNSNet Asset Value(s)
19th Apr 202410:20 amRNSNet Asset Value(s)
18th Apr 202410:20 amRNSNet Asset Value(s)
17th Apr 202410:41 amRNSNet Asset Value(s)
16th Apr 202410:40 amRNSNet Asset Value(s)
15th Apr 20244:37 pmRNSPortfolio Update
15th Apr 202411:45 amRNSNet Asset Value(s)
12th Apr 202411:09 amRNSNet Asset Value(s)
12th Apr 20247:00 amRNSKepler Trust Intelligence: New Research
11th Apr 202410:41 amRNSNet Asset Value(s)
10th Apr 202410:31 amRNSNet Asset Value(s)
9th Apr 202411:10 amRNSNet Asset Value(s)
8th Apr 202411:25 amRNSNet Asset Value(s)
5th Apr 202410:33 amRNSNet Asset Value(s)
4th Apr 202411:06 amRNSNet Asset Value(s)
3rd Apr 202410:40 amRNSNet Asset Value(s)
2nd Apr 202411:15 amRNSNet Asset Value(s)
28th Mar 202411:25 amRNSNet Asset Value(s)
27th Mar 202411:06 amRNSNet Asset Value(s)
26th Mar 202411:45 amRNSNet Asset Value(s)
25th Mar 202411:29 amRNSNet Asset Value(s)
22nd Mar 202410:37 amRNSNet Asset Value(s)
21st Mar 202410:31 amRNSNet Asset Value(s)
20th Mar 202410:41 amRNSNet Asset Value(s)
19th Mar 202410:47 amRNSNet Asset Value(s)
18th Mar 202410:51 amRNSNet Asset Value(s)
15th Mar 202410:39 amRNSNet Asset Value(s)
14th Mar 202410:45 amRNSNet Asset Value(s)
13th Mar 202410:31 amRNSNet Asset Value(s)
12th Mar 202411:06 amRNSNet Asset Value(s)
11th Mar 20243:22 pmRNSDirectorate Change
11th Mar 202410:58 amRNSNet Asset Value(s)
8th Mar 20243:51 pmRNSResult of AGM
8th Mar 202410:40 amRNSNet Asset Value(s)
7th Mar 202410:29 amRNSNet Asset Value(s)
6th Mar 202411:15 amRNSNet Asset Value(s)
5th Mar 202410:21 amRNSNet Asset Value(s)
4th Mar 202411:11 amRNSNet Asset Value(s)
1st Mar 202411:57 amRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.